Muscular Dystrophy Dystroglycanopathy Type B5 C1847759
A form of congenital muscular dystrophy caused by genetic mutations affecting muscle tissue. Severity varies, with symptoms potentially including muscle weakness and other complications.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Congenital muscle weakness
(musculoskeletal)Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Motor developmental delay
(musculoskeletal)Cardiac involvement
(musculoskeletal)Gowers sign
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive Rehabilitation Program
Structured physical therapy program emphasizing gentle resistance training, range of motion exercises, and functional mobility training to preserve muscle function and delay disability progression.
Drug therapy with clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Cardiac Protection and Management
Pharmacological management of cardiomyopathy and arrhythmias with ACE inhibitors, beta-blockers, or other cardiac medications as prescribed by a cardiologist.
Additional treatment options
Psychological Support and Counseling
Mental health support including counseling and therapy to address the emotional challenges of living with a progressive neuromuscular condition, including depression and anxiety management.
psychologicalRegular Disease Progression Monitoring
Scheduled evaluations using standardized functional scales, laboratory tests, and imaging to track disease progression and inform treatment adjustments.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Muscular Dystrophy Dystroglycanopathy Type B5 C1847759?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Muscular Dystrophy Dystroglycanopathy Type B5 C1847759. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy